Strategy | Financing Transactions Private Placement / Financing Transactions Alumis: The company raised $259 million of Series C venture funding in a deal led by Foresite Capital, Samsara BioCapital and venBio on March 6, 2024, putting the company’s pre-money...
Strategy | Financing Transactions Private Placement / Financing Transactions FogPharma: The company raised $145 million of Series E venture funding in a deal led by Nextech Invest on March 1, 2024. GV, Milky Way Investments Group, The Invus Group, Foresite Capital,...
Strategy | Financing Transactions Private Placement / Financing Transactions Procyrion: The company raised $57.7 million in a Series E funding round, including the conversion of $10.0 million of interim financing, on February 5, 2024. The deal was led by Fannin...
Strategy | Financing Transactions Private Placement / Financing Transactions Freenome: The company raised $254 million of venture funding in a deal led by Roche Venture Fund on February 15, 2024, putting the company’s pre-money valuation at $1.95 billion. Bain...
Strategy | Financing Transactions Private Placement / Financing Transactions Neurona Therapeutics: The company raised $120 million of Series E venture funding in a deal led by Viking Global Investors and Cormorant Asset Management on February 8, 2024, putting the...
Strategy | Financing Transactions Private Placement / Financing Transactions Cellanome: The company raised $150 million of Series B venture funding from Premji Invest (US) and undisclosed investors on January 29, 2024, putting the company’s pre-money valuation...
